Related Experiment Video

Updated: Mar 22, 2026

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
09:43

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses

Published on: March 8, 2024

2.6K

CD5: A New Partner for IL-6

Kazuya Masuda1, Tadamitsu Kishimoto1

  • 1Laboratory of Immune Regulation, World Premier International (WPI) Immunology Frontier Research Center (IFReC), Osaka University, Osaka 565-0871, Japan.

Immunity
|April 21, 2016
PubMed

Insights

The interleukin-6 (IL-6) signaling pathway, involving STAT3, drives tumor growth. Researchers found that CD5 binding to IL-6, not IL-6 receptor-α on B cells, enhances STAT3 activation to promote cancer.

Area of Science:

  • Immunology
  • Cancer Biology
  • Molecular Signaling

Background:

  • The interleukin-6 (IL-6) and Signal Transducer and Activator of Transcription 3 (STAT3) signaling pathway is a critical regulator of tumor progression.
  • Understanding the precise mechanisms that amplify IL-6-STAT3 signaling in cancer is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the role of CD5 in modulating IL-6-mediated STAT3 activation in B cells.
  • To determine whether CD5 or IL-6 receptor-α is the primary mediator of enhanced STAT3 activation in the context of cancer.

Main Methods:

  • The study utilized B cell models and analyzed the interaction between IL-6 and CD5.
  • JAK-STAT signaling pathways were assessed to quantify STAT3 activation.
  • Cancer progression markers were evaluated in relation to these signaling events.

Main Results:

  • IL-6 binding to CD5 on B cells was identified as a key amplifier of STAT3 activation.
  • This amplification occurs through the Janus Kinase (JAK)-STAT signaling cascade.
  • The IL-6-CD5 interaction, rather than IL-6 receptor-α, was shown to significantly promote cancer progression.

Conclusions:

  • CD5 plays a pivotal role in enhancing IL-6-driven STAT3 activation, thereby promoting cancer.
  • Targeting the IL-6-CD5 interaction presents a potential therapeutic strategy for cancers driven by this pathway.

More Related Videos

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function09:26

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

Published on: October 15, 2013

14.6K
Isolation of Group 2 Innate Lymphoid Cells from Mouse Nasal Mucosa to Detect the Expression of CD22608:30

Isolation of Group 2 Innate Lymphoid Cells from Mouse Nasal Mucosa to Detect the Expression of CD226

Published on: May 10, 2022

2.7K

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.2K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
17.1K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.8K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
17.9K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.9K